@article{7bcba21a5d65479ea8544256f53e93f8,
title = "Amyloid arthropathy in smoldering myeloma: Do not take it lightly",
abstract = "We report a case of smoldering multiple myeloma patient who developed signs and symptoms consistent with polyarthritis. A PET-CT demonstrated marked FDG activity in multiple joints, concerning for inflammatory arthritis. Arthrocentesis from the glenohumeral joint was consistent with inflammatory synovial fluid with no evidence for infection or crystals. Congo-red stain of the synovial fluid was positive, and mass-spectrometry based amyloid typing was consistent with wild-type transthyretin type. The patient responded instantly to glucocorticoids.",
keywords = "Amyloidosis, Arthrocentesis, Arthropathic, Congo red",
author = "Eli Muchtar and King, {Rebecca L.} and McPhail, {Ellen D.} and Thorpe, {Matthew P.} and Wilson Gonsalves and Floranne Ernste and Martha Grogan and Angela Dispenzieri and Gertz, {Morie A.}",
note = "Funding Information: AD reports scientific board advisory participation for Alnylam, Intellia and Janssen and grants from Takeda, Pfizer, Prothena, Celgene, Alnylam and Janssen. MAG reports consultancy for Millennium Pharmaceuticals and received honoraria from Celgene, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Novartis, GlaxoSmithKline, Prothena, Ionis Pharmaceuticals, and Amgen. The remaining authors declare no competing financial interests. Publisher Copyright: {\textcopyright} 2021",
year = "2021",
month = jan,
doi = "10.1016/j.lrr.2021.100242",
language = "English (US)",
volume = "15",
journal = "Leukemia Research Reports",
issn = "2213-0489",
publisher = "Elsevier Limited",
}